.jpg)
Diabetes, Mood Disorders and ADHD; Brain Hazards and Implications for Improving Clinical Outcomes
Date: May 12, 2018
Location: Missassauga, Ontario, Canada
This archived, self-directed learning activity is available for personal viewing and is based on the live event held in Missasauga, Ontario on May 12 2018. The program involved a multidisciplinary faculty of clinician researchers from Johns Hopkins University School of Medicine, Mount Sinai Hospital, and the University of Toronto. The overarching aim of this learning activity was to:
1. To discuss the hazards on brain function imposed by diabetes mellitus
2. To discuss convergent psychopathology in patients with diabetes, mood disorders and ADHD.
3. To provide practical up to date info on treatment of diabetes mellitus, mood disorders, ADHD with an aim to reduce brain hazards and improve health outcomes
The Panel
Roger McIntyre, MD, FRCPC
Professor of Psychiatry and Pharmacology
Executive Director, BCDF
Head, Mood Disorders Psychopharmacology Unit
University of Toronto
David W. Goodman, MD
Assistant Professor of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine
Director of the Adult Attention Deficit Disorder Center of Maryland in Lutherville
Director of Suburban Psychiatric Associates, LLC
Harpreet Singh Bajaj, MD, MPH, ECNU, FACE
Endocrinologist and Epidemiologist, LMC Diabetes & Endocrinology, Brampton, ON
Research Associate, Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto
Co-Chair, Marketing & Communication, Diabetes Canada National Professional Section
Columnist and blogger, www.medscape.com
Founder, “STOP Diabetes” Foundation Inc.
